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SEROLOGY USING rROP2 ANTIGEN IN THE DIAGNOSTIC OF 
TOXOPLASMOSIS IN PREGNANT WOMEN
Miriam de Souza MACRE (1,2), Márcio PIRES(3), Luciana Regina MEIRELES(1), Sérgio O. ANGEL(4) & Heitor Franco de ANDRADE Jr.(1,5)
SUMMARY
Toxoplasma gondii causes severe fetal disease during acute infection in pregnant women, thus demanding early diagnosis for 
effective treatment and fetus preservation. Fetal tests are inefficient and risky, and diagnosis is based on maternal IgM serology, which 
had weak screening ability due to increased sensitivity, with alternative IgG avidity tests. Here, we performed ELISA and avidity assays 
using a recombinant T. gondii antigen, rROP2, in samples from 160 pregnant women screened from a large public hospital who were 
referred due to positive IgM assays. IgG serology and avidity assays were compared using whole T. gondii extract or rROP2. ELISA 
IgG detection with rROP2 showed good agreement with assays performed with T. gondii extract, but rROP2 IgG avidity assays were 
unrelated to whole extract antigen IgG avidity, regardless of the chaotrope used. These data show that avidity maturation is specific 
to individual antigen prevalence and immune response during infection. ELISA rROP2 IgG assays may be an alternative serological 
test for the diagnosis of toxoplasmosis during pregnancy, although our data do not support their use in avidity assays.
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INTRODUCTION
Toxoplasmosis, which is usually asymptomatic, affects 
approximately 60% of the Brazilian population, resulting in an 
increased risk of congenital infection in hundreds of pregnancies each 
year in the Metropolitan region of São Paulo, where 200,000 children 
are born each year (GUIMARÃES et al., 1993). Diagnosis of acute or 
chronic toxoplasmosis is generally performed by serological assays, 
followed by confirmatory parasitological tests of fetal T. gondii infection 
(CARVALHEIRO et al., 2005). Some serological tests use live agents 
(Sabin Feldman assay), intact parasites, as indirect immunofluorescence 
assays or whole extracts in enzymatic immunosorbent assays to detect 
the presence of specific IgM for definition of acute (less than one year) 
infections during screening for treatment (REMINGTON et al., 2006). 
The development of commercial assays and the use of ultra-sensitive 
techniques such as IgM capture tests increased the sensitivity of these 
assays, but resulted in extended periods of IgM presence after acute 
infections, with consequent loss of screening efficiency (SUZUKI 
et al., 2001). IgG avidity was introduced for temporal definition of 
viral infection in rubella (LEHTONEN & MEURMAN, 1982), and 
was adapted to toxoplasmosis to distinguish recent and old infections 
(HEDMAN et al., 1989). Avidity is based on the binding strength 
of specific IgG to a multivalent antigen of the parasite, which is 
produced at low concentrations after the primary infection, but is 
selectively increased over time. IgG avidity is the summation of specific 
affinities of antibodies present in polyclonal sera against an extract or 
antigen (PELLOUX et al., 1998). High avidity or chaotrope-resistant 
antibodies are characteristic of memory immune response and chronic 
infection, and the prevalence of low avidity or chaotrope-sensitive 
antibodies could indicate acute or recent infection. Urea is the common 
chaotrope used (CAMARGO et al., 1991), an alternative to ammonium 
thiocyanate (FERREIRA & KATZIN, 1995). Several studies have 
reported that the avidity of antibody IgG is a good index of the time 
of the infection, defining if the acute infection has occurred in the past 
few months despite conflicting results between tests (BARBERI et al., 
2001). Recombinant antigens were frequently tested in serology for 
toxoplasmosis (SUZUKI et al, 2001), usually with adequate but weak 
screening results compared to whole extracts in ELISA (VAN GELDER 
et al., 1993). The association of recombinant proteins (AUBERT et al., 
2000, NIGRO et al., 2003, PIETKIEWICZ et al., 2007) or chimeric 
constructions (BEGHETTO et al., 2006) has improved these tests, with 
sporadic use in IgG avidity assays (BEGHETTO et al., 2003). Most 
of these studies were performed on selected sera panels defined by 
other tests, which could interfere in efficacy determination. Here, we 
standardized and tested “in house” ELISA and avidity assays using a 
recombinant rROP2 protein, and compared the results to standard assays 
using whole parasite extract in the serology and avidity determination 
of a population of IgM-positive pregnant women from São Paulo, 
Brazil who were referred to our specific fetal infections research group.
MATERIAL AND METHODS
Population: Pregnant women were referred to the Fetal Infection 
group of the Hospital das Clínicas da Faculdade de Medicina da 
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Universidade de São Paulo (HC-FMUSP) with positive external serology 
for toxoplasmosis IgM by various commercially available tests for routine 
prenatal screening. One hundred sixty patients were enrolled in this study 
after informed consent. All patients were receiving regular spiramycin 
treatment, instituted at the time of positive IgM at a public health clinic, 
usually at least one week before entering the study. Blood was collected 
upon admission for confirmatory serology tests and avidity assays. 
Patients were then monitored clinically and analyzed by morphological 
ultrasound and amniotic fluid sampling when indicated, with subsequent 
parasitological assays or B1 PCR for introducing aggressive therapy. 
This program was approved and controlled by our Ethical Committee, 
CAPPesq under no 365/00.
Antigens: Tachyzoites of T. gondii RH strain were maintained 
routinely in the Laboratory of Protozoology of the Institute of Tropical 
Medicine of São Paulo. Tachyzoites were passaged in serologically 
negative Swiss mice (20-22g, aged 30-60 days) supplied by our 
central colony. The animals were injected with the tachyzoite culture 
intraperitoneally after washing the peritoneal cavity with sterile saline 
solution containing gentamycin (40 μg/mL). All procedures involving 
animals followed the rules described either in “Principles of Laboratory 
Animal Care” (NHI Publication in the 86-23, revised 1985) or “Principles 
of Ethics in Animal Experimentation” (COBEA-Brazilian School of 
Animal Experimentation). 
Toxoplasma gondii whole saline antigen was prepared as previously 
described (CAMARGO et al., 1978). Briefly, tachyzoites from PBS 
washings of the peritoneal cavity of Swiss mice two days after infection 
were flowed over Sephadex G-25 columns for host cell removal and 
recovered by centrifugation. The sediment containing 5x108 tachyzoites 
was suspended in 5.0 mL of water and subjected to sonic rupture, five 
to 10 periods of 30 seconds of 40 Hz, in an ice bath, until complete 
parasite disruption as assessed by phase contrast observation. The solution 
was added to 5 mL of 0.3 M NaCl, which was then homogenized and 
centrifuged at 10,000g for 30 minutes at 4 ºC. Protein concentration of the 
supernatant was calculated, and the supernatant was distributed in aliquots 
of 0.5 mL, frozen at -70 ºC, and used in all experiments as whole extract. 
Recombinant purified rROP2 (MARTIN et al.,1998, NIGRO et al., 
2001) was produced in Escherichia coli cells by transfection with the 
pQE-30 vector containing a fragment of rROP2 mRNA containing 196-
561 base pairs and an adjacent His-Tag and stop codon. The inclusion 
bodies recovered after the cell membranes were disrupted and solubilized 
with 8 M Urea, and the recombinant protein was affinity-purified on 
nickel columns. Protein content was determined and samples were 
distributed and stored at -70 ºC until use. 
Antigen identification by SDS-PAGE and immunoblotting: The 
antigens were characterized by SDS-PAGE and immunoblotting with 
hyper-immune rabbit serum or anti-T. gondii IgG positive and negative 
human sera. Briefly, antigen was suspended in sample buffer containing 
4 M Urea and applied to 10% SDS-PAGE. After running, the proteins 
were transferred to a nitrocellulose membrane (TransBlot Biorad, 
USA) by semidry transfer, and individual strips were reacted with three 
antiserums: anti-T. gondii hyper-immune rabbit serum, anti-T. gondii 
IgG-positive human serum and anti-T. gondii IgG-negative human serum. 
After incubation, each strip was treated with adequate concentrations of 
specific anti-IgG peroxidase conjugates, and bands were visualized with 
diaminobenzidine and H2O2. Strips were mounted according to origin 
and documented. 
Serological and avidity assays: Toxoplasma-specific IgG was 
detected using both an indirect immunofluorescence Assay (IFA) and 
ELISA, while IgM was detected by IFA alone. IFA was performed on 
slides recovered with formalin-fixed tachyzoites. Briefly, tachyzoites 
were obtained from mice and purified as described above, suspended 
in phosphate buffered saline (PBS) with 0.1% of bovine serum albumin 
(BSA) and fixed by the slow addition of one volume of buffered saline 
containing 2% formaldehyde, with constant agitation for 45 minutes 
at 37 oC. Fixed parasites were recovered and washed with PBS by 
centrifugation, adjusted and distributed to multiwell immunofluorescence 
slides, and then drained and stored for use at 4 oC. IFA was performed 
with a 30 minute incubation in a humidified chamber with serial dilutions 
of serum (1/16, 1/32, 1/64, 1/128, 1/256, 1/512, 1/1024), visualized 
with fluorescein-conjugated anti-immunoglobulin IgG or IgM, and 
counterstained with Evans Blue. Positive and negative controls were 
included in all experiments, and the slides were observed by two trained 
observers. A reaction was considered positive when adequate membrane 
fluorescence was clearly seen, although polar or nuclear fluorescence 
were not considered. Before performing IFA assay, all examined sera 
were absorbed with rheumatoid factor reagent (RF-absorbens, Behring). 
ELISA was performed overnight using polystyrene microwell plates 
coated with antigen (10 mg/mL) in carbonate buffer (0.1 M pH 9.0). 
Free sites were blocked with 1% non-fat dry milk in PBS containing 
0.02% Tween-20 (PBST). All subsequent steps were performed with 
four intermediate washes with PBST. Appropriate dilutions of serum 
samples in PBST were then applied, and bound antibody was visualized 
following incubation with appropriate dilutions of peroxidase-conjugated 
anti-human IgG (Sigma). After a 30 minute incubation with 0.05M 
sodium citrate, pH 5.8, containing 0.4 mg/mL o-phenylenediamine 
(OPD), and 0.03% H2O2, the reaction was stopped with the addition 
of 4 N HCl, and 492 nm absorbance is detected in a microplate reader. 
Avidity assays were performed similarly, with the addition of a chaotrope 
washing step between the serum and conjugate incubations. Chaotrope 
solutions were carefully adjusted to pH 7.0 and contained 8 M Urea 
and 1 M Ammonium Thiocyanate. Avidity was expressed as percent of 
specific IgG that remained in the well after being washed with chaotrope 
compared to control wells that were maintained in PBST, subtracting the 
optical density of background conjugate wells. As several dilutions of 
sera were performed in each assay, only the dilution that gives an optical 
density without chaotrope between 0.5 - 1.5 were used for calculation. 
Avidity was arbitrarily defined as low when the percent of the remaining 
absorbance was equal to or lower than 50%, and considered to be high 
when the percent of the remained absorbance was higher than 70%. 
RESULTS
Immunoblotting clearly showed that a specific protein of 
approximately 40 KDa in size was recognized by both rabbit hyper-
immune anti-T. gondii antiserum and anti-T. gondii IgG human serum 
without any labeling with negative human sera, as shown in Figure 1. 
This data allowed us to use an ELISA for IgG using rROP2 antigen, 
which provided similar results to whole saline extract in the same test, 
as seen in Table 1. Using whole saline extract ELISA for IgG as the 
gold standard, the rROP2 assay was in good agreement, with 87% (95% 
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Confidence Interval or CI 60-98%) sensitivity and a efficient specificity 
of 88% (95% IC 82-93), with a high predictive positive value of 98% 
(95% CI 94-100%) despite a low negative predictive value of 43% (95% 
CI 26-62%). 
Our sample was composed of sera from pregnant women who 
reported to the public health network of São Paulo and had a positive 
anti-Toxoplasma IgM test, which was performed during routine anti-
natal serological screening. We retested the women upon admission to 
our study, as seen in Table 1. Clearly, there are many potential pitfalls 
in these screening tests, resulting in large groups of screening errors. 
The first group consisted of seronegative women, which presented IgG 
ELISA-negative results in serological retests at least two weeks after 
screening serology. This group represented 11.3% of the sample (18/160), 
having no contact with Toxoplasma gondii. The second group consisted 
of another type of false positive. These patients had past infections of 
chronic toxoplasmosis, a much more frequent condition, occurring in 
66.9% (107/160) of the samples. After subtracting these two groups of 
false positives, only 21.9% (35/160) of the original sample were pregnant 
women recently infected with Toxoplasma gondii. 
Quantitative distribution of IgG values in rROP2 ELISA can be seen 
in Figure 2. The distribution of IgG values against rROP2 was quite 
diverse in positive samples as compared to negative samples, although 
there were no differences regarding the presence of specific IgM in the 
sample. There is no significant relationship between quantitative data 
from whole extract ELISA as compared to rROP2 ELISA (Fig. 3), both 
in the chronically infected population (IgG+ IgM-) as well as in the 
recently infected population (IgG+ IgM+), suggesting that the amount of 
antibodies against rROP2 do not correlate with whole antigen antibodies. 
We evaluated the avidity of IgG antibodies in these two populations 
using whole extract and rROP2 and two diverse chaotropes in typical 
Fig. 1 - Immunochemical characterization of whole extract antigen and rROP2 antigen was 
revealed by SDS-PAGE with appropriate conjugates. Lanes 1, 3 & 5: Whole T. gondii extract. 
Lanes 2, 4 & 6: purified rROP2. Lanes 1 & 2: Antigen challenged with anti-T. gondii rabbit 
hyper immune serum. Lanes 3 & 4: Antigen challenged with ELISA-positive human sera. 
Lanes 5 & 6: Immunoblot using negative human sera. The arrow depicts rROP2 mobility. 
Table 1
Qualitative and quantitative comparison of ELISA assays for detection of specific IgG and its avidity using whole saline extract (WSE) or rROP2 antigen in IgM-
screened samples from pregnant women reselected by confirmatory specific anti-IgM and IgG IFA assay. Avidity assays were performed only in positive samples 
over cut-off of 99% confidence intervals of confirmed negative samples
Chaotrope Event IgG and IgM 
negative 
IgG negative and 
IgM positive
IgG and IgM 
positive 
IgG positive and 
IgM negative 
Total N 14 4 35 107
ELISA IgG 
WSE positive
0 0 34
97.1%
105
98.1%
Urea WSE 
Low avidity <50%
NA NA 2/34
5.9%
0/105
0%
WSE mean avidity NA NA 83% ± 12 88% ± 12
Thiocyanate WSE 
Low avidity <50%
NA NA 3/34
8.8%
3/105
2.9%
WSE mean avidity NA NA 68% ± 15 72% ± 16
ELISA rROP2 
IgG positive
3
21%
1
25%
34
97.1%
105
98.1%
Urea rROP2 
Low avidity <50%
0/3
0%
0/1
0%
1/34
2.9%
0/105
0%
rROP2 mean avidity 75% 75% 90% ± 12 90% ± 15
Thiocyanate rROP2 
Low avidity <50%
0/3
0%
0/4
0%
8/34
23.6%
19/105
18.1%
rROP2 mean avidity 79% 85% 61% ± 17 62% ± 18
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elution ELISA avidity assays, as described in the Methods section. As 
seen in Figure 4 and Table 1, the mean values of IgG avidity were lower 
in the IgM+ population compared to the IgM- population for the same 
antigen and chaotrope. There are only a few samples with low avidity 
indexes, arbitrarily considered less than 50%, precluding frequency 
comparison between assays and chaotropes. In whole extract avidity, urea 
was a milder chaotrope, resulting in higher avidity indexes in both antigen 
preparations, more clearly seen in IgM+ samples. In rROP2 avidity, this 
chaotrope resulted in no clear definition of recently acquired infections. In 
both assays, the use of ammonium thiocyanate resulted in lower avidity 
indexes, most clearly seen in whole extract ELISA, although those 
indexes were also found in chronic IgM- samples. Whole extract avidity 
indexes presented no relationship with rROP2 avidity indexes, which only 
correlated with the same test using another chaotrope, as shown in Figure 
5. In fact, the relationship between avidity indexes occurred only when 
the same antigen was analyzed with different chaotropes. 
DISCUSSION
Our patient population was composed of pregnant women screened 
for IgM. Most mothers presented high avidity antibodies or false positive 
results, which has been observed in similar studies (SPALDING et al., 
2005). Following a positive test, these patients are usually grouped in the 
Fetal infection Group in Brazil (GUIMARÃES et al., 1993), resulting 
in expensive spiramycin treatment of pregnant women that are not at 
risk of congenital infection, as well as the psychological burden to the 
pregnant women following the suspicion of congenital infection. This 
fact can be attributed to the high proportion of the adult population 
already infected with T. gondii in our area, which results in more IgM 
false positives compared to countries with lower rates of toxoplasmosis 
infection, as several reports relate false positive tests to low cut-off values 
(SUZUKI et al., 2001).
There was good agreement between whole extract serology and 
rROP2 ELISA in our sample of pregnant women screened for Tg IgM 
serology. There were very few negative samples, resulting in high 
accuracy as determined by the kappa test. The rROP2 antigen was of 
good quality as evaluated by immunoblot. rROP2 was further used 
as an antigen for the diagnosis of toxoplasmosis, although the results 
were disappointing (VAN GELDER et al., 1993, MARTIN et al., 1998, 
AUBERT et al., 2000, NIGRO et al., 2003, ALTCHEH et al., 2006, 
PIETKIEWICZ et al., 2007). Our data was similar to those reported by 
VAN GELDER et al. (1993) and those obtained with the same rROP2 
source (MARTIN et al,. 1998, NIGRO et al., 2003). It is important to 
note that the size of the sample used in this study (160 sera) allowed 
us to confirm with great confidence that the version of rROP2 used was 
sufficient to diagnose toxoplasmosis by IgG-ELISA, especially when 
there are several unselected commercial tests in the screening protocol. 
Our study avoids any selection related to the initial IgM test used, as 
the study population consisted of suspected pregnant women screened 
at a reference center under field conditions. Several other recombinant 
antigens give similar results, but they were not included in the commercial 
assays. As the results were similar but weaker than for whole extract 
ELISA, attempts have been made to introduce a mixture of several 
recombinant antigens or chimeric proteins composed of several epitopes 
of diverse T. gondii proteins (BUFFOLANO et al., 2005; BEGHETTO et 
al., 2006; PIETKIEWICZ et al., 2007). However, all attempts have given 
similar results without improving upon the results of the whole extract 
ELISA. It is likely that the use of rROP2-ELISA could be considered 
on the basis of its simple and reliable development. 
Fig. 2 - Distribution of ELISA using rROP2 antigen according to the T. gondii IgG and IgM 
IFA in at-risk pregnant women. Bars represent the mean value. Cutt-off values based on 99% 
confidence intervals of standard negative samples was 0.110. 
Fig. 3 - Relationship between rROP2 and whole extract quantitative ELISA for detecting anti-T. 
gondii IgG in at -risk pregnant women. A: IgG IFA-positive and B: IgG and IgM IFA-positive. 
Shaded areas represent negative cut off area of ELISA rROP2(0.110) and WSE(0.199). 
Fig. 4 - Avidity indexes in IgG-positive at-risk pregnant women selected groups using urea 
or thiocyanate as chaotrope and rROP2 or T. gondii whole extract ELISA. Open symbols 
represent whole extract ELISA; closed symbols represent rROP2 ELISA. Circles represent 
avidity indexes estimated using 8 M Urea as chaotrope. Squares represent avidity indexes 
estimated using 1 M sodium thiocyanate as chaotrope. Bars represent mean values. 
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Avidity data show much more complex results, as there is no 
relationship in quantitative analysis between assays with whole extracts 
or rROP2. The avidity determination was reliable for each isolated 
antigen regardless of the chaotrope agent, demonstrating that avidity 
determination is dependent on each antigen and its preparation for 
determination of recently acquired infections. This data could explain 
the conflicting results reported when comparing commercial tests 
available for avidity determination (BARBERI et al., 2001). Avidity 
is the summation of the specific antibody affinities after an infection. 
Thus, it is dependent on the strain of the parasite and its virulence as well 
as on host factors. There are several strains of T. gondii with variable 
virulence and some antigenic differences, despite the fact that all are 
reactive to whole extract antigens (KONG et al., 2003). These minor 
antigenic differences could affect ELISA with few epitopes, as observed 
in most isolated recombinant protein ELISA, which usually present less 
sensitivity and specificity than whole extract ELISA (BUFFOLANO 
et al., 2005). Another aspect is the parasite load in human infection, 
which can be acquired by oocyst ingestion of only eight sporozoites, 
or by tissue cysts in raw meat, containing several cysts with thousands 
of bradyzoites, as reported in experimental models comparing these 
two ways of infection and reporting that cyst induced infection was 
more acute and severe than oocyst induced infection (DUBEY, 2006). 
Thus, the immune response could be established more effectively in 
oocyst infection, controlling the disease before extensive infection 
and demanding less antibody production and selection. This is the 
main effect in avidity evolution, as the selection of high avidity B cell 
clones is dependent on antigen prevalence and the numbers of clones 
initially produced (TARLINGTON, 2008). Conflicting reports on avidity 
evolution in human toxoplasmosis has been attributed both to individual 
variations and to therapy (LEFEVRE-PETTAZZONI et al., 2006).
Diagnosis of recent T. gondii infection in pregnant women remains 
a difficult task despite scientific efforts to solve this problem. Screening 
tests continue to be based on IgM detection, although our scientific 
improvement on this detection method has only resulted in more false 
positive results and unnecessary treatments and psychological burden 
or, worse, unnecessary pregnancy termination in pregnant women. All 
efforts should be made to standardize antigen preparation in commercial 
tests using purified tachyzoites of standard strains, such as the RH 
strain, with an international consensus on assay procedures, especially 
for avidity assays.
The use of ELISA for specific anti-rROP2 IgG would be an alternative 
serological test for the diagnosis of toxoplasmosis during pregnancy, 
although our data do not support its use in avidity assays for recent 
infection detection. 
RESUMO
Sorologia utilizando o antígeno recombinante ROP2 no  
diagnóstico da toxoplasmose em mulheres grávidas
A toxoplasmose causa grave doença fetal durante a infecção aguda 
da gestante, assim demanda diagnóstico precoce para tratamento efetivo 
e preservação fetal. Os testes fetais são de baixa eficiência e o diagnóstico 
é baseado na sorologia para IgM materna, que tem fraca capacidade de 
triagem devido a sensibilidade crescente dos testes, sendo uma alternativa 
os testes de avidez de IgG. Apresentamos aqui um ELISA e ensaio de 
avidez de IgG usando antígeno recombinante de T. gondii, rROP2, em 
amostras de 162 gestantes triadas para um grande hospital público por 
uma sorologia positiva para IgM. O ELISA IgG e o ensaio de avidez de 
Fig. 5 - Comparison of values of avidity indexes obtained with rROP2 and TgAg using two different chaotropes, Urea or Ammonium Thiocyanate. A: Urea and SCN avidity in WSE assays. 
B: rROP2 and WSE avidity in urea assays. C: Urea and SCN avidity in rROP2 assays. D: rROP2 and WSE avidity in SCN assays.
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IgG foram comparados usando o antígeno rROP2 ou extrato total de T. 
gondii. O ELISA usando rROP2 mostrou excelente concordância com 
os ensaios usando extrato de T. gondii, mas nos ensaios de avidez usando 
rROP2, os valores encontrados não se relacionaram com os encontrados 
na avidez com extrato de T. gondii, independente do tipo de caotrópico 
utilizado. Estes dados mostram que a maturação da avidez é especifica 
para a resposta imune ou a prevalência de um antígeno durante a infecção. 
Os ELISA para IgG anti rROP2 podem ser teste sorológico alternativo 
para o diagnóstico da toxoplasmose durante a gravidez, embora nossos 
dados não apóiem seu uso em ensaios de avidez de IgG.
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